Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal mixture of Terminalia chebula, Commiphora myrrh and Commiphora mukul in diabetic patients with mixed hyperlipidemia
IRCT201307011157N8Phase 2Completed
- Sponsor
- Institute of Medicinal Plant Development
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of terminalia chebula, myrrh and commiphora mukul in type 2 diabetes mellitus (T2DM) and combined dyslipidaemia, sponsored by Institute of Medicinal Plant Development. Started May 2015; status: completed.
02
Drugs
terminalia chebulamyrrhcommiphora mukul
03
Conditions
type 2 diabetes mellitus (T2DM)combined dyslipidaemia
Beyond the preview
Go deeper on IRCT201307011157N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201307011157N8.